Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT04088370
- Status
- Recruiting
Conditions
- Alcoholic Hepatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Blood Draw — OTHERBlood Draw Only
Study Details
Inflammatory responses in response to alcohol have been identified as contributing to the development of alcoholic hepatitis. The inflammatory response including that to LippoPolySaccharide is known to lead to progression of alcoholic liver disease. In addition to the inflammatory response mitochondrial perturbations exist and redox homeostasis is altered in patients with alcoholic hepatitis. Though this is known there have been very few studies targeting mitochondrial function in Peripheral Blood Mononuclear Cells (PBMCs). We plan to collect 50 milliliters of blood from healthy control patients so that we can compare the data to that of patients with alcoholic hepatitis and those who are heavy drinkers without liver disease. In addition to studying mitochondrial function we will investigate cytokine response, as well as fatty acid metabolism, glucose, and insulin measurements
Key Dates
- Start date
- Oct 8, 2019
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: Alcoholic HepatitisNo intervention-blood draw only
- Arm: Healthy ControlsNo intervention- blood draw only
- Arm: Healthy Heavy DrinkersNo intervention- blood draw only
Primary Outcome Measure
Quantify mitochondrial respiration [ Time Frame: 1 day ]
Central Contacts
- Annette Bellar2164456268
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Revathi Penumatsa Srinivasan Dasarathy, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cleveland, OH
Related Studies
- HA35 Moderate Alcoholic Hepatitis (AH) StudyEARLY_PHASE1 · Recruiting · The Cleveland Clinic · Cleveland, Ohio
- Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAHRecruiting · Johns Hopkins University · Baltimore, Maryland
- Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic HepatitisPHASE1/PHASE2 · Recruiting · Prasun Kumar Jalal · Houston, Texas
- Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver DiseaseRecruiting · HepQuant, LLC · Redwood City, California